PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.53%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
0.41%
Positive gross profit growth while BIDU is negative. John Neff would see a clear operational edge over the competitor.
4.92%
Positive EBIT growth while BIDU is negative. John Neff might see a substantial edge in operational management.
4.92%
Positive operating income growth while BIDU is negative. John Neff might view this as a competitive edge in operations.
2.25%
Positive net income growth while BIDU is negative. John Neff might see a big relative performance advantage.
4.00%
Positive EPS growth while BIDU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
No Data
No Data available this quarter, please select a different quarter.
0.44%
Share count expansion well above BIDU's 0.06%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.47%
Diluted share count expanding well above BIDU's 0.07%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-16.17%
Negative OCF growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-31.41%
Negative FCF growth while BIDU is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
2318.93%
10Y revenue/share CAGR under 50% of BIDU's 10085.36%. Michael Burry would suspect a lasting competitive disadvantage.
162.39%
5Y revenue/share CAGR under 50% of BIDU's 1054.34%. Michael Burry would suspect a significant competitive gap or product weakness.
71.93%
3Y revenue/share CAGR under 50% of BIDU's 287.92%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
2057.92%
OCF/share CAGR of 2057.92% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
82.98%
OCF/share CAGR of 82.98% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
32.35%
3Y OCF/share CAGR of 32.35% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
5415.81%
Below 50% of BIDU's 26469.05%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
127.41%
Below 50% of BIDU's 1279.38%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
83.56%
3Y net income/share CAGR 50-75% of BIDU's 135.66%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
12534.36%
Equity/share CAGR of 12534.36% while BIDU is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
188.03%
Below 50% of BIDU's 1137.88%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
79.49%
Below 50% of BIDU's 321.02%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.88%
Firm’s AR is declining while BIDU shows 6.12%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-20.89%
Inventory is declining while BIDU stands at 22.63%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.05%
Asset growth above 1.5x BIDU's 3.37%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.59%
1.25-1.5x BIDU's 3.38%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
19.03%
Debt growth far above BIDU's 2.52%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
0.71%
R&D growth drastically higher vs. BIDU's 1.01%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-4.99%
We cut SG&A while BIDU invests at 7.83%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.